Tong Ren Tang Technologies Co. Ltd. (1666.HK)
1666.HK Stock Price Chart
Explore Tong Ren Tang Technologies Co. Ltd. interactive price chart. Choose custom timeframes to analyze 1666.HK price movements and trends.
1666.HK Company Profile
Discover essential business fundamentals and corporate details for Tong Ren Tang Technologies Co. Ltd. (1666.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
31 Oct 2000
Employees
3.99K
Website
https://www.tongrentangkj.comCEO
Shu Bing Di
Description
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.
1666.HK Financial Timeline
Browse a chronological timeline of Tong Ren Tang Technologies Co. Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Mar 2026
Earnings released on 26 Aug 2025
EPS came in at $0.28 , while revenue for the quarter reached $4.10B .
Dividend declared on 16 Jun 2025
A dividend of $0.20 per share was announced, adjusted to $0.20. The dividend was paid on 11 Aug 2025.
Earnings released on 28 Mar 2025
EPS came in at $0.08 , while revenue for the quarter reached $3.41B .
Earnings released on 30 Aug 2024
EPS came in at $0.36 , while revenue for the quarter reached $4.35B .
Dividend declared on 14 Jun 2024
A dividend of $0.20 per share was announced, adjusted to $0.20. The dividend was paid on 9 Aug 2024.
Earnings released on 22 Mar 2024
EPS came in at $0.19 , while revenue for the quarter reached $3.13B , missing expectations by -62.11%.
Earnings released on 24 Aug 2023
EPS came in at $0.31 , while revenue for the quarter reached $4.27B .
Dividend declared on 19 Jun 2023
A dividend of $0.18 per share was announced, adjusted to $0.18. The dividend was paid on 14 Aug 2023.
Earnings released on 22 Mar 2023
EPS came in at $0.24 , while revenue for the quarter reached $3.39B , missing expectations by -52.72%.
Earnings released on 30 Jun 2022
EPS came in at $0.29 , while revenue for the quarter reached $3.53B .
Dividend declared on 20 Jun 2022
A dividend of $0.19 per share was announced, adjusted to $0.19. The dividend was paid on 15 Aug 2022.
Earnings released on 31 Dec 2021
EPS came in at $0.18 , while revenue for the quarter reached $3.23B .
Earnings released on 30 Jun 2021
EPS came in at $0.30 , while revenue for the quarter reached $3.32B .
Dividend declared on 10 Jun 2021
A dividend of $0.19 per share was announced, adjusted to $0.19. The dividend was paid on 5 Aug 2021.
Earnings released on 31 Dec 2020
EPS came in at $0.18 , while revenue for the quarter reached $2.81B .
1666.HK Stock Performance
Access detailed 1666.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.